載入...
Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection
In the context of the COVID-19 pandemic, several drugs have been repurposed as potential candidates for the treatment of COVID-19 infection. While preliminary choices were essentially based on in vitro potency, clinical translation into effective therapies may be challenging due to unfavorable in vi...
Na minha lista:
| 發表在: | Antiviral Res |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier B.V.
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7351053/ https://ncbi.nlm.nih.gov/pubmed/32659293 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2020.104866 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|